Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of E2027 in Participants With Dementia With Lewy Bodies (DLB) or Parkinson's Disease Dementia (PDD) With or Without Amyloid Copathology

ClinicalTrials.gov ID: NCT04764669

Public ClinicalTrials.gov record NCT04764669. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 6:34 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Study To Evaluate the Pharmacodynamic Effects, Efficacy, Safety, and Tolerability of E2027 in Subjects With Dementia With Lewy Bodies or Parkinson's Disease Dementia With or Without Amyloid Copathology

Study identification

NCT ID
NCT04764669
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eisai Inc.
Industry
Enrollment
34 participants

Conditions and interventions

Interventions

  • E2027 Drug

Drug

Eligibility (public fields only)

Age range
50 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 24, 2021
Primary completion
Dec 7, 2021
Completion
Jan 26, 2022
Last update posted
Sep 25, 2022

2021 – 2022

United States locations

U.S. sites
13
U.S. states
7
U.S. cities
13
Facility City State ZIP Site status
Banner Sun Health Research Institute Sun City Arizona 85351
JEM Research Institute Atlantis Florida 33462
Elias Research Associates (Allied Biomedical Research Institute) Miami Florida 33155
Napa Research Pompano Beach Florida 33064
University of South Florida, Department of Psychiatry and Behavioral Neurosciences Tampa Florida 33613
Alzheimer's Research and Treatment Center Wellington Florida 33414
University of Kentucky, Dept of Neurology, Sanders Brown Center on Aging Lexington Kentucky 40536
Advanced Memory Research Institute of NJPC Toms River New Jersey 08755
Neurological Associates of Albany, PC Albany New York 12208
Columbia University Medical Center New York New York 10032
Neurology Diagnostics, Inc. Dayton Ohio 45459
Cleveland Clinic, Lou Ruvo Center for Brain Health at Lakewood Hospital Lakewood Ohio 44107
Summit Research Network (Oregon) Inc. Portland Oregon 97210

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04764669, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 25, 2022 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04764669 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →